Point72 Hong Kong’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-8,800
Closed -$341K 293
2022
Q3
$341K Buy
8,800
+5,100
+138% +$205K 0.01% 896
2022
Q2
$138K Sell
3,700
-1,400
-27% -$57K 0.01% 1089
2022
Q1
$226K Sell
5,100
-35,100
-87% -$1.52M 0.01% 930
2021
Q4
$1.71M Sell
40,200
-22,400
-36% -$941K 0.06% 394
2021
Q3
$2.72M Buy
+62,600
New +$2.77M 0.09% 325
2021
Q1
Sell
-12,900
Closed -$464K 1826
2020
Q4
$464K Buy
+12,900
New +$465K 0.02% 721

Other funds holding BSX

Point72 Hong Kong's BSX Position: Q3 2025 in Review

Point72 Hong Kong increased its Boston Scientific (BSX) stake by 625% in Q3 2025, buying an estimated $24.3M and bringing the position to 271,689 shares worth $26.5M. The position accounts for 1.22% of the portfolio, ranked #14.

Point72 Hong Kong first reported a position in BSX in Q1 2015 and has held it in 20 quarters since. 1,709 funds tracked by Wall St. Rank hold BSX as of Q3 2025.

  • Point72 Hong Kong held 271,689 shares of Boston Scientific worth $26.5M as of Q3 2025.
  • Point72 Hong Kong bought 234,224 Boston Scientific shares in Q3 2025, an estimated $24.3M.
  • Boston Scientific made up 1.22% of Point72 Hong Kong's portfolio in Q3 2025, its #14 holding.
  • Point72 Hong Kong first reported a position in Boston Scientific in Q1 2015 and has held it in 20 quarters since.
  • 1,709 funds tracked by Wall St. Rank held Boston Scientific as of Q3 2025.

Based on Point72 Hong Kong's 13F filing for Q3 2025, filed 14 Nov 2025.